At this time, extrapolation of the findings of this case to other patients with AITL or other peripheral T cell lymphoma involving TFH cells is premature. AITL patients are rare and their mutation profile is heterogeneous. Furthermore, their immune reactions might be affected by their treatment.
個作者講埋唔好亂咁 extrapolate, 講埋可能係依個病人本身嘅mutation profile 或佢用過嘅癌症治療影響個免疫反應
樓主以為 Croatia (克羅地亞)係美國, 英文好差所以好多英文佢睇唔明, 你將就吓